Patent details

Basic Information

Publication number:

EP3383496

PCT Application Number:

US2016064679

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168715977

PCT Publication Number:

WO2017096201

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY

French Title of Invention:

ONCOTHÉRAPIE CIBLÉE VERS LE RÉCEPTEUR CELLULAIRE DU VIRUS DE LA VALLÉE SENECA (SVV)

German Title of Invention:

GEGEN SENECA VALLEY VIRUS (SVV)-ZELLREZEPTOR GERICHTETE ONKOTHERAPIE

SPC Number:

Dates

Filing date:

02/12/2016

Grant date:

25/05/2022

EP Publication Date:

10/10/2018

PCT Publication Date:

08/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/05/2022

EP B1 Publication Date:

25/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/12/2022

Expiration date:

02/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/05/2022

 

 

Name:

Memorial Sloan-Kettering Cancer Center

Address:

Office of TechnologyDevelopment 1275 York Avenue Box 524, New York, NY 10065, United States (US)

Inventor

1

Name:

MILES, Linde

Address:

United States (US)

2

Name:

RUDIN, Charles

Address:

United States (US)

3

Name:

POIRIER, John

Address:

United States (US)

Priority

Priority Number:

201562262242 P

Priority Date:

02/12/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/00; C12Q 1/6886; G01N 33/53;

Publication

European Patent Bulletin

Issue number:

202221

Publication date:

25/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages